New York, NY -- (SBWIRE) -- 10/27/2017 -- The analysts forecast the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020.

Contract manufacturing involves outsourcing manufacturing products to organizations, which helps the organizations offer the same services at a relatively lower cost. Typically, in the pharmaceutical and biotechnology sectors, the sourcing companies seek contract manufacturing services to restructure their resource deployment toward high skill areas such as R&D and marketing. Contract manufacturing has potential growth opportunities in emerging countries such as India and China.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/742758-global-pharmaceutical-contract-manufacturing-market-2016-2020

For more information or any query mail at sales@wiseguyreports.com

Covered in this report

The report covers the present scenario and the growth prospects of the global pharmaceutical contract manufacturing market for 2016-2020. To calculate the market size, the report considers the revenue generated from various pharmaceutical drug manufacturing outsourcing activities.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Pharmaceutical Contract Manufacturing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Catalent
- Lonza
- Pfizer CentreOne

Other prominent vendors
- Abbott
- Aenova
- Amgen
- Apotex
- Aspen
- AstraZeneca
- Aurobindo Pharma
- Baxter
- BERLIN-CHEMIE
- Biocon
- Biogen
- Boehringer Ingelheim
- Celltrion
- Cipla
- Coherus Biosciences
- Daiichi Sankyo
- Dr. Reddy's Laboratories
- Eli Lilly
- Emcure Pharmaceuticals
- Eurofarma Laboratories
- Fareva
- Gedeon Richter
- Gilead Sciences
- GlaxoSmithKline (GSK)
- Hospira
- Impax Laboratories
- Intas Pharmaceuticals
- Janssen Pharmaceuticals
- Lupin
- Merck
- Mitsubishi Tanabe Pharma
- Momenta Pharmaceuticals
- Natco Pharma
- Nexus Pharmaceuticals
- Novo Nordisk
- Orchid Chemicals & Pharmaceuticals
- Par Pharmaceutical
- Parenteral Drugs India
- Patheon
- Piramal
- Roche Holding
- Sanofi
- Synthon
- Teva Pharmaceuticals
- Valeant Pharmaceuticals
- Zentiva
- Zhejiang Huahai Pharmaceutical
- Zydus Cadila

Market driver
- High number of US FDA-approved manufacturing facilities in emerging countries.
- For a full, detailed list, view our report

Market challenge
- Capacity utilization issues and lack of information integration.
- For a full, detailed list, view our report

Market trend
- Huge demand for next-generation biologics.
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Ask Query @ https://www.wiseguyreports.com/enquiry/742758-global-pharmaceutical-contract-manufacturing-market-2016-2020

Table Of Contents – Major Key Points

PART 01: Executive summary
- Highlights

PART 02: Scope of the report
- Market overview
- Top-vendor offerings

PART 03: Market research methodology
- Research methodology
- Economic indicators

PART 04: Introduction
- Key market highlights

PART 05: Pharmaceutical manufacturing outsourcing
- Increased regulatory guidelines coupled with healthcare cost containment efforts
- Rapid innovation and reduced product development lifecycle
- High capital investment

PART 06: Market landscape
- Market overview
- Five forces analysis

PART 07: Market segmentation by type of contract manufacturing
- Global API/bulk drug contract manufacturing market
- Global FDF market

PART 08: Geographical segmentation
- Global pharmaceutical contract manufacturing market by geography
- Pharmaceutical contract manufacturing market in Americas
- Pharmaceutical contract manufacturing market in APAC
- Pharmaceutical contract manufacturing market in EMEA

PART 09: Key leading countries

PART 10: Market drivers
- Increased focus on core competence
- High number of US FDA-approved manufacturing facilities in emerging countries
- Shorter time-to-market

PART 11: Impact of drivers

PART 12: Market challenges
- Capacity utilization issues and lack of information integration
- Growing global competition
- Lack of manufacturing standardization

PART 13: Impact of drivers and challenges

PART 14: Market trends
- Consolidation through vertical integration, alliances, and acquisitions
- Huge demand for next-generation biologics
- Value-added services

PART 15: Vendor landscape
- Competitive scenario

PART 16: Key vendor analysis
- Catalent
- Lonza
- Pfizer CentreOne
- Other prominent vendors

For more information or any query mail at sales@wiseguyreports.com

About Wise Guy Reports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.